Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness and safety of Olopatadine
Hydrochloride (HCl) ophthalmic solution 0.1% versus Epinastine HCl ophthalmic solution, 0.05%
in a population of healthy, adult Japanese patients (20 years of age or older) with a history
of allergic conjunctivitis to Japanese Cedar Pollen. Patients will be randomly assigned to
receive Olopatadine HCl ophthalmic solution, 0.1% in one eye and Epinastine HCl ophthalmic
solution, 0.05% in the fellow eye, after which a conjunctival allergy challenge (CAC) with
Japanese cedar pollen will be performed.